<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="music/PMC5996544/results/search/drugs/results.xml">
  <result pre="recurrence rates in postmenopausal women by about 30% compared with" exact="tamoxifen" post="while treatments differ. Unfortunately, nearly half of women taking"/>
  <result pre="in clinical practice are the third generation aromatase inhibitors (exemestane," exact="anastrozole" post="and letrozole). AIs improve outcomes in the adjuvant treatment"/>
  <result pre="postmenopausal women with hormone receptor positive (HR+) BC compared with" exact="tamoxifen" post="decreasing the risk of recurrence (20–36%) and decreasing 10-year"/>
  <result pre="radiotherapy. Retrospective analyses indicate prescription-controlled adherence rates of 80% for" exact="tamoxifen" post="and 69% for anastrozole [ 9]. The worst figures"/>
  <result pre="prescription-controlled adherence rates of 80% for tamoxifen and 69% for" exact="anastrozole" post="[ 9]. The worst figures are found in those"/>
  <result pre="cases was higher in those patients who were treated with" exact="exemestane" post="(2,8%) than in those who taking TMX as hormonal"/>
  <result pre="CTS were reported in 2,6% of the participant in the" exact="anastrozole" post="arm, compared with 0.7% in the tamoxifen arm, although"/>
  <result pre="participant in the anastrozole arm, compared with 0.7% in the" exact="tamoxifen" post="arm, although the symptoms were mild or moderate in"/>
  <result pre="strength and they found that a short course of low-dose" exact="prednisone" post="showed promising potential as an effective treatment [ 19]."/>
  <result pre="height, body mass index, waist perimeter and hip perimeter) and" exact="tamoxifen" post="and AIs treatment duration. Table 1 summarises the patients"/>
  <result pre="hormone therapy regimen administered, that is, if they started with" exact="tamoxifen" post="before switching to AIs. In addition to analyzing the"/>
  <result pre="this arthralgia is actually more likely in women switching from" exact="tamoxifen" post="to an AI compared with women starting with AI"/>
  <result pre="AIA AI- induced arthralgia AIs Aromatase Inhibitors ATAC Arimidex and" exact="tamoxifen" post="alone or in combination BADIX Backache Disability Index BAI"/>
  <result pre="R Ingle J Aihara T et al. Aromatase inhibitors versus" exact="tamoxifen" post="in early breast cancer: patient-level meta-analysis of the randomised"/>
  <result pre="symptoms in postmenopausal women with early breast cancer treated with" exact="exemestane" post="or tamoxifen after 2–3 years of tamoxifen: a retrospective"/>
  <result pre="postmenopausal women with early breast cancer treated with exemestane or" exact="tamoxifen" post="after 2–3 years of tamoxifen: a retrospective analysis of"/>
  <result pre="F Bassignana A Miglietta A Antiproliferative effects of COX-2 inhibitor" exact="celecoxib" post="on human breast cancer cell lines Mol Cell Biochem"/>
  <result pre="M Shimada K Yokohata K et al. Short-term and low-dose" exact="prednisolone" post="administration reduces aromatase inhibitor-induced arthralgia in patients with breast"/>
 </snippets>
</snippetsTree>
